|
|
||||||||
Ann Thorac Surg 2007;84:552
© 2007 The Society of Thoracic Surgeons
Department of Cardiology, Johns Hopkins University School of Medicine, Division of Cardiology, Carnegie 568, 600 N Wolfe St, Baltimore, MD 21287
(Email: nkapur3@jhmi.edu).
| The first 20% of the full text of this article appears below. |
Zhao and colleagues [1] evaluated the use of engineered endothelial progenitor cells (EPCs) as a delivery tool for localized expression of prepro-calcitonin gene-related peptide (CGRP) in an animal model of shunt-induced pulmonary hypertension. The authors found that treatment with CGRP-expressing EPCs (CGRP-EPC) attenuated increases in total pulmonary resistance (TPR) and mean pulmonary artery pressure induced by aorto-caval shunts. A secondary finding of the study was a reduction in small pulmonary artery wall thickness after treatment with
Related Article
Ann. Thorac. Surg. 2007 84: 544-552.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |